NCT03387111 2024-08-05QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have ProgressedImmunityBio, Inc.Phase 1/2 Terminated4 enrolled 14 charts
NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT03802058 2023-04-28Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerWuhan UniversityPhase 2 Terminated24 enrolled